PATH homeHomeContact usDonate to PATH
PATH

View this email online

Forward to a friend

Bridging the Gap
   

January 2013

Donate now

 

 

Tackling two threats at once in Cambodia

Fewer children in Cambodia are arriving at local hospitals with life-threatening cases of pneumonia or severe dehydration. An innovative program, launched by PATH in partnership with the Cambodian government, is empowering community volunteers and educating families to tackle the two leading causes of childhood death in Cambodia: pneumonia and diarrheal disease.

After witnessing the devastating effect of these illnesses, Yeksim Chea, the vice-chief of the village Duan Tom, was eager to receive training and bring information about prevention and treatment back to her community. At monthly classes, she and other village health volunteers pass down their knowledge to build awareness among mothers.

Yeksim is proud of the difference she’s making. Read more about her story and Cambodia’s efforts to overcome pneumonia and diarrhea.

A new cervical cancer screening option

Just in time for cervical cancer awareness month—a promising new screening tool is reaching women in need for the first time. Developed in collaboration with PATH, QIAGEN’s careHPV™ delivers results quickly and accurately and can be used even in clinics without laboratories. It will be sold in China this month, a long-awaited breakthrough, and likely will be available in India later this year.

The careHPV™ test has the potential to revolutionize cervical cancer screening in Asia, Africa, and Latin America. Read more about our work to reduce the burden of cervical cancer around the world.

Toward a malaria-free world

Can malaria be eliminated? Not long ago, the idea seemed far-fetched. After all, the mosquito-borne disease is a leading cause of death and illness in tropical and subtropical regions. But we are making progress: malaria deaths have fallen by a third over the last decade.

PATH and our partners are working hard against the disease—from the creation of malaria-free zones in Zambia to a large-scale clinical efficacy trial of the RTS,S malaria vaccine candidate. Stay tuned for the conclusion of the trial this year, with results expected in 2014. In the meantime, explore our updated web feature on malaria to find out more.

Get involved

Join the cyber community in driving global change. PATH supporters now have a chance to contribute directly to selected projects in maternal and child health through Catapult. This new crowdfunding site aims to harness financial and social support to better the lives of women and girls—and their families and communities. Check out our projects in South Africa, Burma, and Vietnam on the Catapult website.

Explore Seattle icons and PATH innovations. Seattle’s Museum of History and Industry (MOHAI) recently reopened its doors in a newly remodeled facility in Lake Union Park. Look for PATH’s technologies on display with other items from Washington’s biotech sector—and explore artifacts that document the rich history of the Puget Sound. Visit MOHAI’s website for more information.

Fill in the blank and win. How would you end this sentence: “Female condoms are ____”? Your response—as a short video—could air at Women Deliver’s third global conference and win up to $5,000. Organized by PATH and our partners, this international film contest seeks creative and compelling stories to raise awareness about female condoms. Submissions will be accepted through March 1, 2013. View the film contest page for more details.

In the news

Nature: Vaccine switch urged for polio endgame (January 14, 2013)

By sunrise on a warm December morning, Janila Shulu’s team are out in the dirt roads and alleyways of Ungwan Rimi . . .

The Times of India: India develops indigenous Japanese encephalitis vaccine (December 17, 2012)

The world’s first vaccine against Japanese encephalitis (JE), created using an Indian strain of the virus, is now ready . . .

Impatient Optimists: Vaccine protects 100 million from meningitis A’s devastation (December 2, 2012)

This week, someone in northern Nigeria—likely a child or teenager—will offer an arm to a health worker, receive a shot of a revolutionary vaccine called MenAfriVac® . . .

For more coverage, visit our press room.

 

Photos: PATH/Heng Chivoan, PATH/Gabe Bienczycki, PATH/Gabe Bienczycki, USAID.

Yeksim Chea

Advocacy efforts pay off: A treaty that limits mercury in the environment protects access to vaccine

Good question!: Delivering safe water to low-resource areas isn't as simple as you might think.

Leadership update: Amie Batson will join PATH as our new chief strategy officer this April.

Charity Navigator: 8 years at four stars

Link: Find us on Facebook

Link: Follow us on Twitter

PATH

PO Box 19210
P: 206.285.3500
development@path.org

|
|
|

Seattle, WA 98109
F: 206.285.6619
www.path.org

We respect the privacy of our online relationships. PATH lists are never sold to third parties. We will only share personally identifiable information with third parties when the person submitting the information authorizes us to share it or we are required to by law.

Opt out of email.

Got this as a forward? Sign up to receive our future emails.

This email was sent to email. To ensure that you continue receiving our emails, please add us to your address book or safe list.

Powered By Blackbaud